Jacobs Levy Equity Management’s ImageneBio, Inc. Common Stock IMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $265K | Sell |
16,509
-3,948
| -19% | -$63.5K | ﹤0.01% | 954 |
|
2025
Q1 | $314K | Sell |
20,457
-6,827
| -25% | -$105K | ﹤0.01% | 972 |
|
2024
Q4 | $537K | Sell |
27,284
-5,112
| -16% | -$101K | ﹤0.01% | 806 |
|
2024
Q3 | $673K | Sell |
32,396
-2,969
| -8% | -$61.6K | ﹤0.01% | 796 |
|
2024
Q2 | $700K | Sell |
35,365
-7,422
| -17% | -$147K | ﹤0.01% | 800 |
|
2024
Q1 | $729K | Buy |
42,787
+38,104
| +814% | +$649K | ﹤0.01% | 766 |
|
2023
Q4 | $111K | Sell |
4,683
-88
| -2% | -$2.08K | ﹤0.01% | 950 |
|
2023
Q3 | $248K | Buy |
4,771
+2,453
| +106% | +$127K | ﹤0.01% | 898 |
|
2023
Q2 | $182K | Buy |
2,318
+806
| +53% | +$63.5K | ﹤0.01% | 932 |
|
2023
Q1 | $62.6K | Buy |
+1,512
| New | +$62.6K | ﹤0.01% | 939 |
|
2022
Q3 | – | Sell |
-3,410
| Closed | -$181K | – | 1087 |
|
2022
Q2 | $181K | Buy |
+3,410
| New | +$181K | ﹤0.01% | 962 |
|